Literature DB >> 20953981

A comparative study of faecal occult blood kits in a colorectal cancer screening program in a cohort of healthy construction workers.

M Shuhaibar1, C Walsh, F Lindsay, N Lee, P Walsh, P O'Gorman, G Boran, R McLoughlin, A Qasim, N Breslin, B Ryan, H O'Connor, C O'Morain.   

Abstract

BACKGROUND: The incidence of colorectal cancer (CRC) has been increasing. We evaluated uptake rates and outcomes of faecal immunochemical test (FIT) and Guaiac test (gFOBT) kits as part of a two-step CRC screening.
METHODS: A 3-year CRC screening program for a defined population of construction workers was conducted. Those satisfying the inclusion criteria were provided with gFOBT or FIT kits. Individuals testing positive were invited for a colonoscopy.
RESULTS: A total of 909 faecal testing kits were distributed. Age range was 53-60 years. Compliance rate was higher for FIT (58.3%) as compared to gFOBT (46.7%) (p = 0.0006). FIT detected adenomatous polyps and CRC in 37.5 and 25%, respectively, whereas; gFOBT detected 23.5 and 18%. Colonoscopies were normal in 53 and 25% tested positive by gFOBT and FIT, respectively (p = 0.016).
CONCLUSION: The FIT was more cost-effective when compared with gFOBT with higher return rate, sensitivity and specificity. A comparative study of faecal occult blood kits in a CRC screening program in a healthy cohort of construction workers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20953981     DOI: 10.1007/s11845-010-0605-0

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  32 in total

1.  The effect of fecal occult-blood screening on the incidence of colorectal cancer.

Authors:  J S Mandel; T R Church; J H Bond; F Ederer; M S Geisser; S J Mongin; D C Snover; L M Schuman
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

2.  Colorectal cancer screening using immunochemical faecal occult blood testing in Japan.

Authors:  Hiroshi Saito
Journal:  J Med Screen       Date:  2006       Impact factor: 2.136

Review 3.  The adenoma-carcinoma sequence and prospects for the prevention of colorectal neoplasia.

Authors:  S Cotton; L Sharp; J Little
Journal:  Crit Rev Oncog       Date:  1996

Review 4.  Clinical evidence for the adenoma-carcinoma sequence, and the management of patients with colorectal adenomas.

Authors:  J H Bond
Journal:  Semin Gastrointest Dis       Date:  2000-10

5.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.

Authors:  J D Hardcastle; J O Chamberlain; M H Robinson; S M Moss; S S Amar; T W Balfour; P D James; C M Mangham
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

6.  Randomised study of screening for colorectal cancer with faecal-occult-blood test.

Authors:  O Kronborg; C Fenger; J Olsen; O D Jørgensen; O Søndergaard
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

7.  Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68,308 subjects.

Authors:  J Kewenter; H Brevinge; B Engarås; E Haglind; C Ahrén
Journal:  Scand J Gastroenterol       Date:  1994-05       Impact factor: 2.423

8.  Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results.

Authors:  G Grazzini; G Castiglione; C Ciabattoni; F Franceschini; D Giorgi; S Gozzi; P Mantellini; P Lopane; M Perco; T Rubeca; P Salvadori; C B Visioli; M Zappa
Journal:  Eur J Cancer Prev       Date:  2004-02       Impact factor: 2.497

9.  Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16).

Authors:  Li-Sheng Chen; Chao-Sheng Liao; Shu-Hui Chang; Hsin-Chih Lai; Tony Hsiu-Hsi Chen
Journal:  J Med Screen       Date:  2007       Impact factor: 2.136

10.  Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design.

Authors:  Nea Malila; Tiina Oivanen; Outi Malminiemi; Matti Hakama
Journal:  BMJ       Date:  2008-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.